Crispr Therapeutics' current revenue from CASGEVY is limited by high costs, profit-sharing, and logistical hurdles. Click ...

Achieves FDA Alignment on CMC and Non-Clinical Toxicology Regulatory Path for Nebokitug in PSC— —Preparations for the Nebokitug PSC Phase 3 Clinical Trial Advance as Discussions with Potential ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...

Your bedtime screen time is not just delaying your sleep, it’s ruining your sleep cycle and mental health. And if you think ...

Duavee, approved for menopause, may help prevent invasive breast cancer by slowing cell growth in breast cancer, offering a ...

Diana Moser has, to the best of her knowledge, not contracted Lyme disease, a welcome status quo that might be credited to ...

DelveInsight's Alzheimer's Disease Pipeline report depicts a robust space with 200+ active players working to develop 220+ ...

Evogene Ltd. has unveiled a first-in-class generative AI foundation model for small-molecule design, marking a breakthrough ...

In a world where celebrities dominate headlines and social media feeds, one event stands apart by turning the spotlight on an ...

“From the personalized sleep quiz to the first night’s rest, it’s clear this mattress was designed with real-life ... Cycle. “And if you’re waking up sore or groggy, a mattress upgrade is overdue.” ...

The best time to take melatonin is 30 minutes to one hour before your desired bedtime. Learn more about the best time to take ...

What are the benefits and risks of using medication known as gonadotropin-releasing hormone (GnRH) agonists and antagonists in the management of premenstrual syndrome (PMS)?